ABIVAX Société Anonyme (0RA9.L)

EUR 7.35

(-0.34%)

Net Debt Summary of ABIVAX Société Anonyme

ABIVAX Société Anonyme's latest annual net debt in 2023 was -196.47 Million EUR , down -1093.47% from previous year.
ABIVAX Société Anonyme's latest quarterly net debt in 2024 Q2 was -111.17 Million EUR , down 0.0% from previous quarter.
ABIVAX Société Anonyme reported annual net debt of 19.77 Million EUR in 2022, up 372.82% from previous year.
ABIVAX Société Anonyme reported annual net debt of -7.24 Million EUR in 2021, down -254.69% from previous year.
ABIVAX Société Anonyme reported quarterly net debt of -196.47 Million EUR for 2023 Q4, down 0.0% from previous quarter.
ABIVAX Société Anonyme reported quarterly net debt of -196.47 Million EUR for 2023 FY, down -1093.47% from previous quarter.

Annual Net Debt Chart of ABIVAX Société Anonyme (2023 - 2013)

Historical Annual Net Debt of ABIVAX Société Anonyme (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	-196.47 Million EUR	-1093.47%
2022	19.77 Million EUR	372.82%
2021	-7.24 Million EUR	-254.69%
2020	4.68 Million EUR	-57.31%
2019	10.97 Million EUR	278.03%
2018	2.9 Million EUR	279.37%
2017	-1.61 Million EUR	70.09%
2016	-5.41 Million EUR	-264.28%
2015	3.29 Million EUR	279.19%
2014	868.96 Thousand EUR	247.85%
2013	-587.71 Thousand EUR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-111.17 Million EUR	0.0%
2023 Q4	-196.47 Million EUR	0.0%
2023 FY	-196.47 Million EUR	-1093.47%
2023 Q2	-79.69 Million EUR	0.0%
2022 Q2	22.9 Million EUR	0.0%
2022 Q4	19.77 Million EUR	0.0%
2022 FY	19.77 Million EUR	372.82%
2021 FY	-7.24 Million EUR	-254.69%
2021 Q2	27.46 Million EUR	0.0%
2021 Q4	-7.24 Million EUR	0.0%
2020 FY	4.68 Million EUR	-57.31%
2020 Q2	12.43 Million EUR	0.0%
2020 Q4	4.68 Million EUR	0.0%
2019 Q4	10.97 Million EUR	0.0%
2019 FY	10.97 Million EUR	278.03%
2019 Q2	10.25 Million EUR	0.0%
2018 Q2	-2.57 Million EUR	0.0%
2018 FY	2.9 Million EUR	279.37%
2018 Q4	2.9 Million EUR	0.0%
2017 Q4	-1.61 Million EUR	0.0%
2017 FY	-1.61 Million EUR	70.09%
2017 Q2	-945 Thousand EUR	0.0%
2016 Q4	-7.62 Million EUR	0.0%
2016 Q2	-715 Thousand EUR	0.0%
2016 FY	-5.41 Million EUR	-264.28%
2015 Q4	286 Thousand EUR	0.0%
2015 FY	3.29 Million EUR	279.19%
2015 Q2	-53.1 Million EUR	0.0%
2014 Q4	868.96 Thousand EUR	71267.98%
2014 Q3	-1221.00 EUR	0.0%
2014 FY	868.96 Thousand EUR	247.85%
2014 Q1	- EUR	0.0%
2013 FY	-587.71 Thousand EUR	0.0%

Peer Net Debt Comparison of ABIVAX Société Anonyme

Name	Net Debt	Net Debt Difference
Boiron SA	-60.34 Million EUR	-225.607%
Laboratorios Farmaceuticos Rovi, S.A.	21.31 Million EUR	1021.869%
Vetoquinol SA	-129.83 Million EUR	-51.328%
Valneva SE	82.73 Million EUR	337.476%
AB Science S.A.	13.03 Million EUR	1607.311%
Nanobiotix S.A.	-29.8 Million EUR	-559.322%
PHAXIAM Therapeutics S.A.	-275 Thousand EUR	-71346.545%
Vivoryon Therapeutics N.V.	-18.52 Million EUR	-960.667%
BioSenic S.A.	28.04 Million EUR	800.606%
Formycon AG	2.45 Million EUR	8116.238%